Cargando…

Identification of a 5-lncRNA signature-based risk scoring system for survival prediction in colorectal cancer

The present study aimed to investigate potential prognostic long noncoding RNAs (lncRNAs) associated with colorectal cancer (CRC). An mRNA-seq dataset obtained from The Cancer Genome Atlas was employed to identify the differentially expressed lncRNAs (DELs) between CRC patients with good and poor pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Liqiang, Yu, Jun, Wang, Qing, Xu, Bin, Ji, Liechen, Yu, Lin, Zhang, Xipeng, Cai, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059680/ https://www.ncbi.nlm.nih.gov/pubmed/29749517 http://dx.doi.org/10.3892/mmr.2018.8963

Ejemplares similares

LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT
por: Ji, Liechen, et al.
Publicado: (2021)

Exploration of Potential Roles of m6A Regulators in Colorectal Cancer Prognosis
por: Ji, Liechen, et al.
Publicado: (2020)

lncRNA RMST suppresses the progression of colorectal cancer by competitively binding to miR-27a-3p/RXRα axis and inactivating Wnt signaling pathway: RMST suppresses the progression of colorectal cancer
por: Chen, Shuo, et al.
Publicado: (2023)

Evaluation of serum midkine and carcinoembryonic antigen as diagnostic biomarkers for rectal cancer and synchronous metastasis
por: Ji, Liechen, et al.
Publicado: (2020)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis
por: Li, Shuyuan, et al.
Publicado: (2020)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma
por: Ji, Yanping, et al.
Publicado: (2020)

A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer
por: Zhong, Xinyang, et al.
Publicado: (2022)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for predicting colorectal cancer patients’ survival
por: Liu, Feng, et al.
Publicado: (2023)

Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2019)

Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma
por: Zeng, Jiang-Hui, et al.
Publicado: (2017)

The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer
por: Huang, Liang, et al.
Publicado: (2021)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
por: Li, Jiagen, et al.
Publicado: (2014)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients
por: Song, Wei, et al.
Publicado: (2021)

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
por: Li, Zhiyong, et al.
Publicado: (2022)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
por: Huang, Rui, et al.
Publicado: (2020)

Novel three-lncRNA signature predicts survival in patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2018)

Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
por: Li, Xiaoying, et al.
Publicado: (2020)

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
por: Hou, Dong, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs
por: Ma, Di, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer
por: Zhang, Ruyue, et al.
Publicado: (2021)

A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer
por: Wang, Xuning, et al.
Publicado: (2018)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gj2095c1e8frmmabjtrdm44u3l